


Executive Conference Corporation
The mission of ECC Webinars is to provide the pharmaceutical, biotech, and medical device industries with leading edge and informative webinars led by experts in their fields, fostering a stronger knowledge base in the workforce.
"The Difference is Distictive"
Instructor
Barry A. Friedman
Barry A. Friedman, Ph.D., is a Senior Consultant in the Biotechnology, Regulatory Compliance, Microbiology and Aseptic Processing arena. From 2000 to 2007, Dr. Friedman was associated with Cambrex Bio Science Baltimore, a contract manufacturer of GMP bulk biopharmaceuticals located in Baltimore, MD. In that capacity as the Director, Quality Control, he managed a multi-shift Department of thirty one individuals involved in Client management, the receipt and testing of raw materials, environmental monitoring and microbiology, analytical chemistry and QC compliance for the production of Phase 1, 2, 3 and commercial products manufactured from bacteria, yeast and mammalian cells. In this capacity Dr Friedman enjoyed many client and regulatory compliance interactions.
Dr. Friedman has over 30 years of industrial managerial experience in various aspects of biopharmaceuticals and medical devices to include regulatory compliance, expert witness assistance, quality control, sterility assurance, microbiological/analytical validations and fermentation technology. In addition to the associations listed above, other associations have included Chesapeake Biological Laboratories, W.R. Grace, Sigma Chemical Co., Sherwood Medical, Becton Dickinson, American Cyanamid and Union Carbide.
Dr. Friedman is a frequent seminar and webinar speaker and specializes in the areas of regulatory compliance, internal auditing, aseptic processing for sterile drug products, USP and Warning Letter “dissection”, multi-departmental interactions, validations and the requirements for the manufacture of Phase 1, 2 and 3 clinical trial materials. He has recently given presentations for the FDA, PDA, PTi, TungstenShield, IPA (Canada) and Pharmig (UK). He maintains an active Blog
www.barryafriedmanphdllc.com contains over 200 Blogs that address various Warning Letter and FDA 483 issues as well as over 1,500 “Search” terms. He is a member of ASM, PDA and RAPs. He served as a Captain in the Medical Service Corps, U.S. Army and is the past President and current Treasurer of the Capital Area Chapter, PDA. He recently received the James Agalloco award from PDA which is awarded to a PDA faculty member who exemplifies outstanding performance in education.
Barry A. Friedman: Upcoming and Archived Webinars
-
ECC-669
04/29/2025
upcoming
MICROBIOLOGY FOR THE NON-MICROBIOLOGIST – AND THE MICROBIOLOGIST WHO DESIRES A GMP MICROBIOLOGICAL REFRESHER
-
ECC-670
04/24/2025
upcoming
The Microbiology of Water in a GMP Environment
-
ECC-671
04/22/2025
upcoming
VALIDATION MASTER PLANNING (DEVELOPING A COMPREHENSIVE VALIDATION PACKAGE)
-
ECC-668
03/27/2025
archive
Risk Management of Raw Materials in a GMP Environment
-
ECC-661
01/29/2025
archive
Good Laboratory Practices (GLP) vs. Good Manufacturing Practices (GMPs) — A Comparison and Contrast – “Why One Should Use Only GMP Facilities for Manufacturing and Testing”
-
ECC-660
01/22/2025
archive
Risk Management of Raw Materials in a GMP Environment
-
ECC-659
01/16/2025
archive
Bioburden Control of Non-Sterile Drug Substances and Products– A New USP General Information Chapter
-
ECC-658
01/15/2025
archive
Development of a Steam Autoclave Sterilization Validation Plan
-
ECC-654
12/12/2024
archive
VALIDATION MASTER PLANNING (DEVELOPING A COMPREHENSIVE VALIDATION PACKAGE)
-
ECC-653
12/04/2024
archive
MICROBIOLOGY FOR THE NON-MICROBIOLOGIST – AND THE MICROBIOLOGIST WHO DESIRES A GMP MICROBIOLOGICAL REFRESHER
-
ECC-652
12/03/2024
archive
THE BACTERIAL ENDOTOXINS TEST (ISSUES AND SOLUTIONS) TO INCLUDE THE ISSUE OF LOW ENDOTOXIN RECOVERY (LER) AND TR 82 (PDA) AND GENERAL INFORMATION CHAPTER <1085>
-
ECC-648
11/21/2024
archive
Risk Management and The New General Chapter, USP<60>, Burkholderia cepacia
-
ECC-647
11/19/2024
archive
Good Laboratory Practices (GLP) vs. Good Manufacturing Practices (GMPs) — A Comparison and Contrast – “Why One Should Use Only GMP Facilities for Manufacturing and Testing”
-
ECC-646
11/14/2024
archive
Managing Microbiological Out of Specification (OOS) and Out of Trend (OOT) Results in Sterile and Non-Sterile ProductionFDA and ICH Expectations and Guidance
-
ECC-645
11/13/2024
archive
Risk Management of Raw Materials in a GMP Environment
-
ECC-640
10/29/2024
archive
The Microbiology of Water in a GMP Environment
-
ECC-639
10/09/2024
archive
FDA Contract Manufacturing Arrangements for Drugs: Quality Agreements - Their Relationship to Microbiological Issues
-
ECC-638
10/02/2024
archive
Annual Laboratory Microbiology Training
-
ECC-637
10/01/2024
archive
Bioburden Control of Non-Sterile Drug Substances and Products– A New USP General Information Chapter
-
ECC-636
09/26/2024
archive
Process Simulation Testing for Aseptically Filled Products
-
ECC-635
09/24/2024
archive
VALIDATION MASTER PLANNING (DEVELOPING A COMPREHENSIVE VALIDATION PACKAGE)
-
ECC-633
09/05/2024
archive
TERMINALLY STERILIZED PHARMACEUTICAL PRODUCTS—PARAMETRIC RELEASE (NEW USP<1222>, November 2019) AND ITS RELATIONSHIP TO THE NEW BRITISH TERMINAL STERILIZATION METHODOLOGY (March 2019)
-
ECC-627
08/27/2024
archive
Risk Management of Raw Materials in a GMP Environment
-
ECC-624
08/21/2024
archive
THE BACTERIAL ENDOTOXINS TEST (ISSUES AND SOLUTIONS) TO INCLUDE THE ISSUE OF LOW ENDOTOXIN RECOVERY (LER) AND TR 82 (PDA) AND GENERAL INFORMATION CHAPTER <1085>
-
ECC-626
08/15/2024
archive
Development of a Steam Autoclave Sterilization Validation Plan